CN Patent

CN116583316A — 用于吸入器测试的系统和方法

Assigned to Proveris Scientific Co · Expires 2023-08-11 · 3y expired

What this patent protects

本公开提供了一种剂量收集仪器，其包括第一导管和第二导管，该第一导管包括第一入口端口和第一流体流动路径，该第二导管包括第二入口端口和第二流体流动路径。

USPTO Abstract

本公开提供了一种剂量收集仪器，其包括第一导管和第二导管，该第一导管包括第一入口端口和第一流体流动路径，该第二导管包括第二入口端口和第二流体流动路径。

Drugs covered by this patent

umeclidinium-bromide (UMECLIDINIUM BROMIDE)

Patent Metadata

Patent number: CN116583316A
Jurisdiction: CN
Classification: —
Expires: 2023-08-11
Drug substance claim: No
Drug product claim: No
Assignee: Proveris Scientific Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.